• Home
  • Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.

Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer.

Author List
Drain AP, Zahir N, Northey JJ, Zhang H, Huang PJ, Maller O, Lakins JN, Yu X, Leight JL, Alston-Mills BP, Hwang ES, Chen YY, Park CC, Weaver VM
Publication
The Journal of experimental medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/186877110
Publication Year
2021
PubMed ID
33822843
Publication Title
Drain AP, Zahir N, Northey JJ, Zhang H, Huang PJ, Maller O, Lakins JN, Yu X, Leight JL, Alston-Mills BP, Hwang ES, Chen YY, Park CC, Weaver VM. Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer. J Exp Med. 2021 05 03; 218(5).